PATENT CLAIM ANALYSIS

Application Number: 16119306
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["548", "264200"]

Abstract:
The present application relates to solid state forms of a triazolone compound which exhibit mPGES-1 enzyme inhibition activity, specifically N-(4-chloro-3-(5-oxo-1-(4-(trifluoromethyl)phenyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)benzyl) pivalamide (Compound of formula II), and process for preparation thereof.

Claim (Index 31):
A process for preparation of N-(4-chloro-3-(5-oxo-1-(4-(trifluoromethyl)phenyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)benzyl)pivalamide (Compound formula II) or a salt thereof, which process comprises the steps of:\n a) reacting 2-chloro benzoic acid with 2,2,2-trifluoro-N-(hydroxymethyl)acetamide to obtain substantially pure compound of formula (VI) \n b) converting the compound of formula (VI) to compound of formula (IV) c) reacting the compound of formula (IV) with oxalyl chloride and a compound of formula (V) to obtain the compound of formula (III) and\n d) converting compound of formula (III) to compound of formula (II).

Metadata:
- Claim Count in Document: 11.0
- Percentile: 96.0
- Lexical Diversity: 1.25
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15573387', '15762523', '15919460', '14402608', '13060388']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7483137281859413
- 35 USC 102 Novelty (BERT): 0.5989435624449369
- Combined Prediction Score: 0.7333767116118409
- Mean Citation Score: 292.5759520000001
- Max Citation Score: 537.5445599999998
- Similarity Product: 460.7345741318893

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test